Literature DB >> 16554743

Effect of antidepressant drugs in mice lacking the norepinephrine transporter.

Marta Dziedzicka-Wasylewska1, Agata Faron-Górecka, Maciej Kuśmider, Elzbieta Drozdowska, Zofia Rogóz, Joanna Siwanowicz, Marc G Caron, Heinz Bönisch.   

Abstract

One of the main theories concerning the mechanism of action of antidepressant drugs (ADs) is based on the notion that the neurochemical background of depression involves an impairment of central noradrenergic transmission with a concomitant decrease of the norepinephrine (NE) in the synaptic gap. Many ADs increase synaptic NE availability by inhibition of the reuptake of NE. Using mice lacking NE transporter (NET-/-) we examined their baseline phenotype as well as the response in the forced swim test (FST) and in the tail suspension test (TST) upon treatment with ADs that display different pharmacological profiles. In both tests, the NET-/- mice behaved like wild-type (WT) mice acutely treated with ADs. Autoradiographic studies showed decreased binding of the beta-adrenergic ligand [3H]CGP12177 in the cerebral cortex of NET-/- mice, indicating the changes at the level of beta-adrenergic receptors similar to those obtained with ADs treatment. The binding of [3H]prazosin to alpha1-adrenergic receptors in the cerebral cortex of NET-/- mice was also decreased, most probably as an adaptive response to the sustained elevation of extracellular NE levels observed in these mice. A pronounced NET knockout-induced shortening of the immobility time in the TST (by ca 50%) compared to WT mice was not reduced any further by NET-inhibiting ADs such as reboxetine, desipramine, and imipramine. Citalopram, which is devoid of affinity for the NET, exerted a significant reduction of immobility time in the NET-/- mice. In the FST, reboxetine, desipramine, imipramine, and citalopram administered acutely did not reduce any further the immobility time shortened by NET knockout itself (ca 25%); however, antidepressant-like action of repeatedly (7 days) administered desipramine was observed in NET-/- mice, indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test. From the present study, it may be concluded that mice lacking the NET may represent a good model of some aspects of depression-resistant behavior, paralleled with alterations in the expression of adrenergic receptors, which result as an adaptation to elevated levels of extracellular NE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16554743     DOI: 10.1038/sj.npp.1301064

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  21 in total

1.  Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain.

Authors:  S Ohnami; A Kato; K Ogawa; S Shinohara; H Ono; M Tanabe
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis.

Authors:  Yun Ma; Jessica J Krueger; Sara N Redmon; Sasidhar Uppuganti; Jeffry S Nyman; Maureen K Hahn; Florent Elefteriou
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

3.  Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.

Authors:  Jermaine D Jones; F Scott Hall; George R Uhl; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2009-12-04       Impact factor: 3.533

4.  Long-term citalopram maintenance in mice: selective reduction of alcohol-heightened aggression.

Authors:  Elizabeth E Caldwell; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2007-10-20       Impact factor: 4.530

5.  Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.

Authors:  Maria T G Perona; Shonna Waters; Frank Scott Hall; Ichiro Sora; Klaus-Peter Lesch; Dennis L Murphy; Marc Caron; George R Uhl
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

6.  Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression.

Authors:  Britta Haenisch; Andras Bilkei-Gorzo; Marc G Caron; Heinz Bönisch
Journal:  J Neurochem       Date:  2009-08-18       Impact factor: 5.372

7.  The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.

Authors:  Gor Sarkisyan; Amanda J Roberts; Peter B Hedlund
Journal:  Behav Brain Res       Date:  2010-01-25       Impact factor: 3.332

8.  MicroRNAs 29b and 181a down-regulate the expression of the norepinephrine transporter and glucocorticoid receptors in PC12 cells.

Authors:  Maoxian Deng; Turan Tufan; Muhammad U Raza; Thomas C Jones; Meng-Yang Zhu
Journal:  J Neurochem       Date:  2016-09-22       Impact factor: 5.372

9.  Effect of desipramine and citalopram treatment on forced swimming test-induced changes in cocaine- and amphetamine-regulated transcript (CART) immunoreactivity in mice.

Authors:  Sung Chung; Hee Jeong Kim; Hyun Ju Kim; Sun Hye Choi; Jin Wook Kim; Jeong Min Kim; Kyung Ho Shin
Journal:  Neurochem Res       Date:  2014-04-20       Impact factor: 3.996

10.  Association between polymorphism of the norepinephrine transporter gene rs2242446 and rs5669 loci and depression disorders.

Authors:  Yu Pan; Qi Cheng; Mo-Shui Shan; Jin Yan
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.